📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Genomas

1.1 - Company Overview

Genomas Logo

Genomas

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of DNA-guided medicine products that bring personalized prescription of drugs to clinical practice, targeting treatments for mental illness, diabetes, and cardiovascular disease, and aimed at eliminating trial-and-error prescribing.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Genomas

Ocean Ridge Biosciences Logo

Ocean Ridge Biosciences

HQ: United States Website
  • Description: Provider of accurate, affordable, and information-rich genomic services to the Health Care and Life Science industries. A life science company in the research tools sector of biotechnology, headquartered in Deerfield Beach and centrally located within the South Florida metropolis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ocean Ridge Biosciences company profile →
Nebula Genomics Logo

Nebula Genomics

HQ: United States Website
  • Description: Provider of blockchain-enabled whole genome sequencing (30x and 100x coverage) and a trusted genomic and health data marketplace that ensures consumer data control. Offers Nebula Explore reporting membership, a curated research library, genome exploration tools, and deep genetic ancestry using full mtDNA and Y-DNA sequencing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nebula Genomics company profile →
RNAissance Ag Logo

RNAissance Ag

HQ: United States Website
  • Description: Provider of ribonucleic acid and RNAi products, offering innovative technology for large-scale fermentation-based production of exogenous RNAi, addressing mass production challenges and enabling farmers to protect and improve crops and cattle.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full RNAissance Ag company profile →
GenoSpace Logo

GenoSpace

HQ: United States Website
  • Description: Provider of a precision medicine software platform that makes biomedical data useful and usable, enabling interpretation, analysis, reporting, and collaboration. Offers clinical trial matching using clinical-genomic data, EMR-to-EDC integration to transfer EMR data to clinical trial databases, and study feasibility and site selection tools evaluating enrollment potential and competing trials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GenoSpace company profile →
SNIPR Biome Logo

SNIPR Biome

HQ: Denmark Website
  • Description: Provider of CRISPR-based microbial gene therapies that selectively target and eliminate hazardous bacteria without harming beneficial microbes; gut-directed gene therapy via engineered bacteria; CRISPR-Guided Vectors (CGV) for rapid, precise bacterial killing; platforms for in situ therapeutic protein and peptide production; backed by an extensive patent portfolio and research collaborations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SNIPR Biome company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Genomas

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Genomas

2.2 - Growth funds investing in similar companies to Genomas

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Genomas

4.2 - Public trading comparable groups for Genomas

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Genomas

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Genomas

What does Genomas do?

Genomas is a provider of DNA-guided medicine products that bring personalized prescription of drugs to clinical practice, targeting treatments for mental illness, diabetes, and cardiovascular disease, and aimed at eliminating trial-and-error prescribing.

Who are Genomas's competitors?

Genomas's competitors and similar companies include Ocean Ridge Biosciences, Nebula Genomics, RNAissance Ag, GenoSpace, and SNIPR Biome.

Where is Genomas headquartered?

Genomas is headquartered in United States.

How many employees does Genomas have?

Genomas has 1,000 employees 🔒.

When was Genomas founded?

Genomas was founded in 2010 🔒.

What sector and industry vertical is Genomas in?

Genomas is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Genomas

Who are the top strategic acquirers in Genomas's sector and industry

Top strategic M&A buyers and acquirers in Genomas's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Genomas?

Top strategic M&A buyers groups and sectors for Genomas include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Genomas's sector and industry vertical

Which are the top PE firms investing in Genomas's sector and industry vertical?

Top PE firms investing in Genomas's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Genomas's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Genomas's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Genomas's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Genomas include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Genomas's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Genomas?

The key public trading comparables and valuation benchmarks for Genomas include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Genomas for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Genomas with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Genomas's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Genomas with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Genomas's' sector and industry vertical?

Access recent funding rounds and capital raises in Genomas's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Genomas